Sushmita M. Chanda
Corporate Officer/Principal bei ALIGOS THERAPEUTICS, INC.
Profil
Sushmita M.
Chanda is currently the Executive VP-Translational Safety Sciences at Aligos Therapeutics, Inc. Prior to this, she was the Vice President-Preclinical Development at Alios BioPharma, Inc. from 2010 to 2018.
From 2000 to 2010, she worked at F.
Hoffmann-La Roche Ltd.
as the Senior Director & Head-Nonclinical Safety.
Chanda holds a doctorate degree from the University of Louisiana at Monroe and undergraduate and graduate degrees from Birla Institute of Technology Mesra.
Aktive Positionen von Sushmita M. Chanda
| Unternehmen | Position | Beginn |
|---|---|---|
| ALIGOS THERAPEUTICS, INC. | Corporate Officer/Principal | 01.08.2018 |
Ehemalige bekannte Positionen von Sushmita M. Chanda
| Unternehmen | Position | Ende |
|---|---|---|
Alios BioPharma, Inc.
 Alios BioPharma, Inc. Pharmaceuticals: MajorHealth Technology Alios BioPharma, Inc. operates as a clinical stage biopharmaceutical company which develops novel antiviral therapies for the treatment of respiratory diseases. It also develops proprietary chemical libraries of novel nucleosides, nucleoside analogs and non-nucleosides as potential therapeutics for viral infections including RSV, influenza, rhinovirus and emerging viral diseases. The firm offers VX-135, a uridine nucleotide analog for the treatment of chronic hepatitis C. The company was founded by Leonid N. Beigelman, Lawrence M. Blatt and John R. Donovan in 2008 and is headquartered in San Francisco, CA. | Corporate Officer/Principal | 01.07.2018 |
F. Hoffmann-La Roche Ltd.
 F. Hoffmann-La Roche Ltd. Pharmaceuticals: MajorHealth Technology F. Hoffmann-La Roche Ltd. manufactures pharmaceutical products. It offers pharmaceutical drugs, pharmaceutical instruments, and diagnostics solutions. The company was founded by Fritz Hoffmann-La Roche on October 1, 1896 and is headquartered in Basel, Switzerland. | Corporate Officer/Principal | 01.01.2010 |
Ausbildung von Sushmita M. Chanda
| University of Louisiana at Monroe | Doctorate Degree |
| Birla Institute of Technology Mesra | Graduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| ALIGOS THERAPEUTICS, INC. | Health Technology |
| Private Unternehmen | 2 |
|---|---|
F. Hoffmann-La Roche Ltd.
F. Hoffmann-La Roche Ltd. Pharmaceuticals: MajorHealth Technology F. Hoffmann-La Roche Ltd. manufactures pharmaceutical products. It offers pharmaceutical drugs, pharmaceutical instruments, and diagnostics solutions. The company was founded by Fritz Hoffmann-La Roche on October 1, 1896 and is headquartered in Basel, Switzerland. | Health Technology |
Alios BioPharma, Inc.
Alios BioPharma, Inc. Pharmaceuticals: MajorHealth Technology Alios BioPharma, Inc. operates as a clinical stage biopharmaceutical company which develops novel antiviral therapies for the treatment of respiratory diseases. It also develops proprietary chemical libraries of novel nucleosides, nucleoside analogs and non-nucleosides as potential therapeutics for viral infections including RSV, influenza, rhinovirus and emerging viral diseases. The firm offers VX-135, a uridine nucleotide analog for the treatment of chronic hepatitis C. The company was founded by Leonid N. Beigelman, Lawrence M. Blatt and John R. Donovan in 2008 and is headquartered in San Francisco, CA. | Health Technology |
